These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 20213607

  • 1. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?
    Ponticelli C, Passerini P.
    J Nephrol; 2010; 23(2):156-63. PubMed ID: 20213607
    [Abstract] [Full Text] [Related]

  • 2. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 3. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H, Lee H, Lee JP, Kim DK, Oh S, Oh YK, Kim YS, Lim CS.
    BMC Nephrol; 2017 Mar 27; 18(1):104. PubMed ID: 28347297
    [Abstract] [Full Text] [Related]

  • 4. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF.
    Nephrol Dial Transplant; 2007 Aug 27; 22(8):2201-7. PubMed ID: 17442739
    [Abstract] [Full Text] [Related]

  • 5. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 27; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 6. Remission of proteinuria with treatment of Actinomyces infection: eradicating a cause of secondary membranous glomerulopathy suppresses nephrotic syndrome.
    Yoon SY, Lee SC, Park YJ, Rha SH.
    Nephrol Dial Transplant; 2009 Oct 27; 24(10):3236-9. PubMed ID: 19515799
    [Abstract] [Full Text] [Related]

  • 7. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2010 Jan 27; 25(1):129-36. PubMed ID: 19666912
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C.
    Nephrol Dial Transplant; 1989 Jan 27; 4(6):525-9. PubMed ID: 2507973
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 27; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 10. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 27; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 11. [Membranous glomerulonephritis].
    Polenaković M.
    Srp Arh Celok Lek; 1996 May 27; 124 Suppl 1():18-25. PubMed ID: 9102898
    [Abstract] [Full Text] [Related]

  • 12. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
    Laluck BJ, Cattran DC.
    Am J Kidney Dis; 1999 Jun 27; 33(6):1026-32. PubMed ID: 10352189
    [Abstract] [Full Text] [Related]

  • 13. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC, Sethi S, Specks U.
    Clin J Am Soc Nephrol; 2008 May 27; 3(3):905-19. PubMed ID: 18235148
    [Abstract] [Full Text] [Related]

  • 14. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center.
    Sprangers B, Bomback AS, Cohen SD, Radhakrishnan J, Valeri A, Markowitz GS, D'Agati V, Appel GB.
    Am J Nephrol; 2012 May 27; 36(1):78-89. PubMed ID: 22739228
    [Abstract] [Full Text] [Related]

  • 15. Early prediction of treatment outcome in idiopathic membranous nephropathy.
    O'Callaghan CA, Cameron JS, Sacks SH.
    QJM; 1995 Dec 27; 88(12):889-94. PubMed ID: 8593548
    [Abstract] [Full Text] [Related]

  • 16. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
    Murphy BF, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1988 Oct 27; 30(4):175-81. PubMed ID: 3214963
    [Abstract] [Full Text] [Related]

  • 17. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy.
    Tsuboi N, Kawamura T, Miyazaki Y, Utsunomiya Y, Hosoya T.
    Nephrol Dial Transplant; 2011 Nov 27; 26(11):3555-60. PubMed ID: 21771759
    [Abstract] [Full Text] [Related]

  • 18. The treatment of idiopathic membranous nephropathy.
    Geddes CC, Cattran DC.
    Semin Nephrol; 2000 May 27; 20(3):299-308. PubMed ID: 10855940
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 27; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 20. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 27; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.